BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$14.18
−1.29%Forward multiples
Based on analyst estimates
- P/E forward
- 17.78x
- P/E 2026E
- 18.32x
- P/E 2027E
- 15.47x
- P/E 2028E
- 13.41x
- P/S forward
- 1.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.64x
- PEG TTM
- —
- Price / book
- 4.24x
- Price / sales
- 1.66x
- Price / cash flow
- 9.99x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 2.15x
- EV / EBITDA
- 13.48x
- EV / EBIT
- 20.24x
- Market cap
- $968.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026